| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532296 |
NSE Symbol : GLENMARK |
P/E(TTM) : 37.18 |
|
ISIN Demat : INE935A01035 |
Div & Yield% : 0.13 |
EPS(TTM) : 52.14 |
|
Book Value(₹) : 848.31 |
Market Cap(₹Cr) : 54,700.39 |
Face Value(₹) : 1.00 |
| Company Background | |
|---|---|
| Incorporation Year | 1977 |
| Registered Office | B/2 Mahalaxmi Chambers Mumbai Maharashtra 400026 |
| Telephone | 91-22-40189999 |
| Fax | 91-22-40189986 |
| Chairman | Glenn Saldanha |
| Managing Director | Glenn Saldanha |
| Company Secretary | Harish Kuber |
| Auditor | Suresh Surana & Associates LLP |
| Face Value | 1.0 |
| Market Lot | 1 |
| Listing |
BSE
MSEI
NSE
|
| Registrar | KFin Techologies Ltd Karvy Selenium Tow-B,31&32 Financial Dist,Nanakramguda,Hyderabad-500032 |